Hillevax Ownership

HLVX Stock  USD 1.91  0.03  1.55%   
Hillevax has a total of 49.81 Million outstanding shares. The majority of Hillevax outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hillevax to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hillevax. Please pay attention to any change in the institutional holdings of Hillevax as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Hillevax in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Hillevax, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Paid And Capex Coverage Ratio is likely to drop to -8.48 in 2024. Common Stock Shares Outstanding is likely to drop to about 37.1 M in 2024. Net Loss is likely to rise to about (136.6 M) in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hillevax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Hillevax Stock please use our How to Invest in Hillevax guide.

Hillevax Stock Ownership Analysis

About 17.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hillevax recorded a loss per share of 3.09. The entity had not issued any dividends in recent years. HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. Hillevax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people. To learn more about Hillevax call the company at 617 213 5054 or check out https://www.hillevax.com.
Besides selling stocks to institutional investors, Hillevax also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Hillevax's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Hillevax's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Hillevax Quarterly Liabilities And Stockholders Equity

220.62 Million

About 17.0% of Hillevax are currently held by insiders. Unlike Hillevax's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Hillevax's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Hillevax's insider trades

Hillevax Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Hillevax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hillevax backward and forwards among themselves. Hillevax's institutional investor refers to the entity that pools money to purchase Hillevax's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
627.7 K
State Street Corp2024-06-30
595.4 K
Qiming U.s. Ventures Management, Llc2024-09-30
558.9 K
Millennium Management Llc2024-06-30
490 K
Trium Capital Llp2024-09-30
453.3 K
Deutsche Bank Ag2024-06-30
311.6 K
Northern Trust Corp2024-09-30
242.7 K
Catalys Pacific Llc2024-09-30
236.4 K
Citadel Advisors Llc2024-09-30
175.5 K
Tang Capital Management Llc2024-09-30
4.9 M
Blackrock Inc2024-06-30
2.1 M
Note, although Hillevax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hillevax Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hillevax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hillevax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hillevax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Frazier Life Sciences X, L.p. over three weeks ago
Disposition of 2736234 shares by Frazier Life Sciences X, L.p. of Hillevax at 13.6 subject to Rule 16b-3
 
Gerberding Julie L. over three weeks ago
Disposition of tradable shares by Gerberding Julie L. of Hillevax subject to Rule 16b-3
 
Borkowski Astrid over a month ago
Disposition of 10000 shares by Borkowski Astrid of Hillevax at 14.2 subject to Rule 16b-3
 
Aditya Kohli over a month ago
Disposition of 8866 shares by Aditya Kohli of Hillevax at 14.9315 subject to Rule 16b-3
 
Borkowski Astrid over two months ago
Disposition of 10000 shares by Borkowski Astrid of Hillevax at 14.5 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.205 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 15.4482 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 723 shares by Aditya Kohli of Hillevax at 14.1542 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.0135 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.7075 subject to Rule 16b-3
 
Sean McLoughlin over six months ago
Acquisition by Sean McLoughlin of 1250 shares of Hillevax at 16.98 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 17.4153 subject to Rule 16b-3

Hillevax Outstanding Bonds

Hillevax issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hillevax uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hillevax bonds can be classified according to their maturity, which is the date when Hillevax has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hillevax Stock Analysis

When running Hillevax's price analysis, check to measure Hillevax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hillevax is operating at the current time. Most of Hillevax's value examination focuses on studying past and present price action to predict the probability of Hillevax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hillevax's price. Additionally, you may evaluate how the addition of Hillevax to your portfolios can decrease your overall portfolio volatility.